We are live on
!
Find out more
Janux Therapeutics
JANX
JANX
181 hedge funds and large institutions have $1.81B invested in Janux Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 96 increasing their positions, 45 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
295% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $4.35M
113% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 45
1.5% more ownership
Funds ownership: 110.97% → 112.47% (+1.5%)
16% less funds holding
Funds holding: 216 → 181 (-35)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
47% less capital invested
Capital invested by funds: $3.43B → $1.81B (-$1.63B)
66% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 53
Holders
181
Holders Change
-35
Holders Change %
-16.2%
% of All Funds
2.43%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.09%
New
18
Increased
96
Reduced
45
Closed
53
Calls
$17.2M
Puts
$4.35M
Net Calls
+$12.8M
Net Calls Change
-$5.21M
Top Buyers
Top Sellers
| 1 |
Holocene Advisors
New York
|
-$54.3M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$27.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$24.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$18.2M |
